Drug Type Small molecule drug |
Synonyms V 0162, V-0162, V0162 + [1] |
Mechanism M1 receptor antagonists(Muscarinic acetylcholine receptor M1 antagonists), M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists), M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22N2S |
InChIKeyHOKDBMAJZXIPGC-MRXNPFEDSA-N |
CAS Registry147780-50-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 2 | BE | - | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | FR | - | |
Urinary Incontinence | Phase 2 | - | - |